# General Considerations for the Clinical Evaluation of Drugs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/general-considerations-for-the-clinical-evaluation-of-drugs/9f83d453-bc55-45a5-962d-87455db6263c

> FDA guidance document: General Considerations for the Clinical Evaluation of Drugs. Issue date: January 01, 1997. Get complete insights and analysis.

---

## Details

- Title: General Considerations for the Clinical Evaluation of Drugs
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1997-01-01
- Last Changed: 2019-03-20

## Related Documents

- [Study of Drugs Likely to be used in the Elderly](https://www.globalkeysolutions.net/guidances/guidance-document/study-of-drugs-likely-to-be-used-in-the-elderly/00cfcd92-8ac1-4307-968b-117b25f0493c)
- [Psychoactive Drugs in Infants and Children--Clinical Evaluation](https://www.globalkeysolutions.net/guidances/guidance-document/psychoactive-drugs-in-infants-and-children-clinical-evaluation/0474cb88-76c3-4dcd-9de2-3adb6d22efec)
- [Preparation of Investigational New Drug Products (Human and Animal):  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/preparation-of-investigational-new-drug-products-human-and-animal-guidance-for-industry/4382914f-5b98-4ad4-91c1-ed6e2893e213)